SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-130392
Filing Date
2011-05-06
Accepted
2011-05-06 14:04:40
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 616914
2 CERTIFICATION OF THE CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex311.htm EX-31.1 8023
3 CERTIFICATION OF THE CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex312.htm EX-31.2 8087
4 CERTIFICATION REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 4239
  Complete submission text file 0001193125-11-130392.txt   1963616

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xnpt-20110331.xml EX-101.INS 223607
6 XBRL TAXONOMY EXTENSION SCHEMA xnpt-20110331.xsd EX-101.SCH 12326
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xnpt-20110331_cal.xml EX-101.CAL 30226
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xnpt-20110331_def.xml EX-101.DEF 67921
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE xnpt-20110331_lab.xml EX-101.LAB 71601
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xnpt-20110331_pre.xml EX-101.PRE 74367
Mailing Address 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051 4086167200
XENOPORT INC (Filer) CIK: 0001130591 (see all company filings)

IRS No.: 943330837 | State of Incorp.: DE | Fiscal Year End: 1230
Type: 10-Q | Act: 34 | File No.: 000-51329 | Film No.: 11818519
SIC: 2834 Pharmaceutical Preparations